Innopran xl side effects by duration, gender and age - a phase IV clinical study of FDA data

< 1 month:

1. Activities of daily living impaired
2. Balance disorder
3. Bradycardia (abnormally slow heart action)
4. Dysphonia (speech disorder attributable to a disorder of phonation)

1 - 6 months:

1. Angiopathy (generic term for a disease of the blood vessels)
2. Depressed mood

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

1. Pelvic fracture

10+ years:

n/a

not specified:

1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
3. Completed suicide (act of taking one's own life)
4. Dizziness
5. Febrile neutropenia (fever with reduced white blood cells)
6. Nasal obstruction (blockage of nose)
7. Accelerated idioventricular rhythm (rate of cardiac contraction)
8. Agitation (state of anxiety or nervous excitement)
9. Alopecia (absence of hair from areas of the body)
10. Anaemia (lack of blood)

female:

1. Blood pressure increased
2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
3. Death
4. Dizziness
5. Nasal obstruction (blockage of nose)
6. Accelerated idioventricular rhythm (rate of cardiac contraction)
7. Activities of daily living impaired
8. Agitation (state of anxiety or nervous excitement)
9. Alopecia (absence of hair from areas of the body)
10. Anaemia (lack of blood)

male:

1. Depressed mood
2. Febrile neutropenia (fever with reduced white blood cells)
3. Muscle twitching
4. Sluggishness (lacking alertness)
5. Arteriosclerosis (thickening and hardening of arteries)
6. Bladder disorder
7. Blood testosterone decreased
8. Bradycardia (abnormally slow heart action)
9. Death
10. Drug ineffective

0-1:

1. Nasal obstruction (blockage of nose)
2. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

2-9:

n/a

10-19:

n/a

20-29:

1. Anxiety
2. Lupus-like syndrome (a disease symptom matches with lupus an immune disease)

30-39:

1. Completed suicide (act of taking one's own life)
2. Agitation (state of anxiety or nervous excitement)
3. Balance disorder
4. Dizziness
5. Dysphonia (speech disorder attributable to a disorder of phonation)
6. Low density lipoprotein increased (cholesterol increased in blood)

40-49:

1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
2. Bradycardia (abnormally slow heart action)
3. Death
4. Muscle twitching
5. Sluggishness (lacking alertness)

50-59:

1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
2. Blood pressure increased
3. Arteriosclerosis (thickening and hardening of arteries)
4. Asthenia (weakness)
5. Depressed mood
6. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

60+:

1. Febrile neutropenia (fever with reduced white blood cells)
2. Activities of daily living impaired
3. Anaphylactic reaction (serious allergic reaction)
4. Angiopathy (generic term for a disease of the blood vessels)
5. Blood creatinine increased
6. Blood pressure increased
7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
8. Chest discomfort
9. Coronary arterial stent insertion
10. Death